Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

GlaxoSmithKline reported GBP1.95B in Operating Profit for its fiscal quarter ending in September of 2023.

Operating Profit Change Date
AbbVie USD 2.28B 2.23B Sep/2023
Alcon AG USD 293M 23M Sep/2023
Almirall EUR 38.88M 39.82M Jun/2023
Amgen USD 2.09B 594M Sep/2023
Artemis Alpha GBP -16578000 10.12M Jun/2022
AstraZeneca USD 1.95B 502M Sep/2023
Bayer EUR -3594000000 2.64B Sep/2023
Biogen USD 158.8M 428.1M Sep/2023
Bristol-Myers Squibb USD 2.33B 191M Sep/2023
Galapagos EUR -30233000 19.54M Sep/2023
Genmab DKK 1.72B 220M Sep/2023
Gilead Sciences USD 2.62B 958M Sep/2023
GlaxoSmithKline GBP 1.95B 192M Sep/2023
GRIFOLS EUR 250.59M 7.19M Sep/2023
Hikma Pharmaceutical USD 243M 183M Jun/2023
Lonza CHF 540M 356M Jun/2023
Merck EUR 983M 14M Sep/2023
Merck USD 5.77B 10.93B Sep/2023
Orion EUR 80M 33.5M Sep/2023
Pfizer USD -2927000000 5.1B Sep/2023
Philips EUR 224M 3M Sep/2023
Recordati EUR 126.18M 14.74M Sep/2023
Regeneron Pharmaceuticals USD 1.11B 94.5M Sep/2023
Roche Holding CHF 9.76B 3.84B Jun/2023
Smith & Nephew USD 275M 67M Jun/2023
UCB EUR 480M 385M Jun/2023